BN Business News
Ajouter votre entreprise →
Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.

Commerce international · 06/04/20231 min de lecture

Certain Dermatological Treatment Devices and Components Thereof; Institution of Investigation

Traduction automatique locale · Langue originale de la source

Résumé

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on March 1, 2023, under section 337 of the Tariff Act of 1930, as amended, on behalf of Serendia, LLC of Lake Forest, California. Supplements were filed on March 2, 13 and 14, 2023. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain dermatological treatment devices and components thereof by reason of the infringement of certain claims of U.S. Patent No. 9,480,836 ("the '836 Patent"); U.S. Patent No. 10,058,379 ("the '379 Patent"); U.S. Patent No. 11,406,444 ("the '444 Patent"); U.S. Patent No. 9,320,536 ("the '536 Patent"); U.S. Patent No. 9,775,774 ("the " '774 Patent"); and U.S. Patent No. 10,869,812 ("the '812 Patent"). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

Langue originale de la source: Federal Register — International Trade CommissionOuvrir le communiqué original →

Explorer les analyses

Analyses business →